{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:47:46Z","timestamp":1792673266689,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.06.135","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T14:39:21Z","timestamp":1467383961000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells"],"prefix":"10.1016","volume":"511","author":[{"given":"Jenni J.","family":"Hakkarainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symantas","family":"Ragauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aila","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giedrius","family":"Kalesnykas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.06.135_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17469899.4.1.59","article-title":"Preservatives in topical ophthalmic medications: historical and clinical perspectives","volume":"4","author":"Freeman","year":"2009","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003226-199211030-00006","article-title":"Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride","volume":"11","author":"Ichijima","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0020","doi-asserted-by":"crossref","DOI":"10.3109\/15569527.2015.1058272","article-title":"Acute corneal toxicity of latanoprost with different preservatives","author":"Uematsu","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1755-3768.1985.tb01557.x","article-title":"Contact allergy to components in topical ophthalmologic preparations","volume":"63","author":"H\u00e4tinen","year":"1985","journal-title":"Acta Ophthalmol. (Copenh.)"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","article-title":"Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication","volume":"88","author":"Uusitalo","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0035","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2010.0003","article-title":"In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells","volume":"26","author":"Kahook","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12325-011-0029-x","article-title":"Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells","volume":"28","author":"Ammar","year":"2011","journal-title":"Adv Ther."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0050","first-page":"1189","article-title":"The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells","volume":"18","author":"Paimela","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0055","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/jop.2013.0002","article-title":"Comparison of the effects of ophthalmic solutions on human corneal epithelial cells using fluorescent dyes","volume":"29","author":"Xu","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0060","first-page":"175","article-title":"Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells","volume":"2","author":"Smedowski","year":"2014","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0065","first-page":"5626","article-title":"The effect of IOP-lowering eye drops and their excipients on human corneal epithelial cells [ARVO2015 Poster]","volume":"56","author":"Shen","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/jop.2010.0175","article-title":"Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity: comparison of acute corneal barrier dysfunction induced by travoprost Z and travoprost","volume":"27","author":"Uematsu","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/ICO.0000000000000086","article-title":"Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride","volume":"33","author":"Onizuka","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1542-0124(11)70024-6","article-title":"Preservative use in topical glaucoma medications","volume":"9","author":"Tressler","year":"2011","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0085","series-title":"Bioadhesive drug delivery systems","first-page":"185","article-title":"Ocular bioadhesive delivery systems","author":"Middleton","year":"1990"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0090","series-title":"Center for Drug Evaluation and Research. Inactive Ingredient Search for Approved Drug Products (Database)","author":"U.S. Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0095","first-page":"614","article-title":"An SV40-immortalized human corneal epithelial cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cyto.a.10067","article-title":"A new nondestructive cytometric assay based on resazurin metabolism and an organ culture model for the assessment of corneal viability","volume":"55","author":"Perrot","year":"2003","journal-title":"Cytometry A"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tiv.2012.07.011","article-title":"A human hemi-cornea model for eye irritation testing: quality control of production, reliability and predictive capacity","volume":"27","author":"Engelke","year":"2013","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0014-4835(03)00054-X","article-title":"Tight junction-related protein expression and distribution in human corneal epithelium","volume":"76","author":"Ban","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0115","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2010.189449","article-title":"Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system","volume":"95","author":"Liang","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/02713683.2011.626909","article-title":"The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo","volume":"37","author":"Pellinen","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yrtph.2013.03.014","article-title":"Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines","volume":"66","author":"Iwasawa","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2016.06.135_bib0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1211\/jpp.60.3.0004","article-title":"Cell culture models of the human cornea\u2fffa comparative evaluation of their usefulness to determine ocular drug absorption in-vitro","volume":"60","author":"Reichl","year":"2008","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T16:52:38Z","timestamp":1536598358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316306251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316306251"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.135","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.06.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}